{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T15:19:48Z","timestamp":1776784788862,"version":"3.51.2"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Genomic instability is a hallmark of cancer, encompassing both sequence and structural alterations that drive tumor evolution and heterogeneity. The APOBEC3 family of deoxycytidine deaminases has emerged as a major source of mutagenic activity in cancers. R-loops are RNA-DNA hybrids and structural barriers that interfere with replication and transcription. Among the APOBEC3 family, APOBEC3C (A3C) is particularly worthy of attention for its upregulation, driving the DNA replication stress tolerance in response to replication stress-inducing drug gemcitabine. However, the molecular mechanisms of gemcitabine resistance and regulatory circuitries mediated by A3C remain largely unknown, especially in checkpoint-deficient tumors. Initially, we screened that A3C was a putative transcriptional target of p53, and p53-deficient H1299 cells harboring A3C elicited a chemoresistant phenotype upon gemcitabine treatment both in vitro and in vivo. A3C expression enhanced Chk1-dependent S-phase checkpoint activation, thus slowing down replication fork progression and facilitating DNA repair. Pull-down assay and proteomic analysis identified that A3C had a specific interaction with the RNA helicase DDX5, which coordinately played critical roles in R-loop resolution. In contrast to A3C, DDX5 expression attenuated Chk1-dependent S-phase checkpoint activation. Knockdown of DDX5 in A3C-proficient H1299 cells attenuated gemcitabine-induced Chk1 activation and enhanced the therapeutic index of gemcitabine by promoting R-loop accumulation. Therefore, we conclude that A3C\/DDX5\/R-loop complex may impair the sensitivity of gemcitabine by modulating Chk1 dynamics and DNA replication\/damage response machinery.<\/jats:p>","DOI":"10.1038\/s41419-025-08215-6","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T14:52:11Z","timestamp":1767797531000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["APOBEC3C coordinates DDX5 in R-loop resolution and dynamic control of Chk1-mediated stress-responsive circuitry as a prerequisite for gemcitabine resistance in p53-deficient cells"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9835-4744","authenticated-orcid":false,"given":"Li","family":"Tao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuangzhaung","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanlin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tengyang","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"8215_CR1","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/ng.2702","volume":"45","author":"SA Roberts","year":"2013","unstructured":"Roberts SA, Lawrence MS, Klimczak LJ, Grimm SA, Fargo D, Stojanov P, et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet. 2013;45:970\u20136.","journal-title":"Nat Genet"},{"key":"8215_CR2","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41586-022-04972-y","volume":"607","author":"M Petljak","year":"2022","unstructured":"Petljak M, Dananberg A, Chu K, Bergstrom EN, Striepen J, von Morgen P, et al. Mechanisms of APOBEC3 mutagenesis in human cancer cells. Nature. 2022;607:799\u2013807.","journal-title":"Nature"},{"key":"8215_CR3","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.200188","volume":"10","author":"M Granadillo Rodriguez","year":"2020","unstructured":"Granadillo Rodriguez M, Flath B, Chelico L. The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead. Open Biol. 2020;10:200188.","journal-title":"Open Biol"},{"key":"8215_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.ccell.2024.03.010","volume":"42","author":"AN Hata","year":"2024","unstructured":"Hata AN, Larijani M. Targeting APOBECs in cancer: It\u2019s about timing. Cancer Cell. 2024;42:497\u2013501.","journal-title":"Cancer Cell"},{"key":"8215_CR5","doi-asserted-by":"publisher","first-page":"iyae092.","DOI":"10.1093\/genetics\/iyae092","volume":"227","author":"GW Brown","year":"2024","unstructured":"Brown GW. The cytidine deaminase APOBEC3C has unique sequence and genome feature preferences. Genetics. 2024;227:iyae092.","journal-title":"Genetics"},{"key":"8215_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-022-00411-9","volume":"11","author":"Y Qian","year":"2022","unstructured":"Qian Y, Gong Y, Zou X, Liu Y, Chen Y, Wang R, et al. Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma. Oncogenesis. 2022;11:35.","journal-title":"Oncogenesis"},{"key":"8215_CR7","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s43018-024-00742-z","volume":"5","author":"T Ubhi","year":"2024","unstructured":"Ubhi T, Zaslaver O, Quaile AT, Plenker D, Cao P, Pham NA, et al. Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cells. Nat Cancer. 2024;5:895\u2013915.","journal-title":"Nat Cancer"},{"key":"8215_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111067","volume":"40","author":"S Saha","year":"2022","unstructured":"Saha S, Yang X, Huang SN, Agama K, Baechler SA, Sun Y, et al. Resolution of R-loops by topoisomerase III-beta (TOP3B) in coordination with the DEAD-box helicase DDX5. Cell Rep. 2022;40:111067.","journal-title":"Cell Rep"},{"key":"8215_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/narcan\/zcaa028","volume":"2","author":"Z Yu","year":"2020","unstructured":"Yu Z, Mersaoui SY, Guitton-Sert L, Coulombe Y, Song J, Masson JY, et al. DDX5 resolves R-loops at DNA double-strand breaks to promote DNA repair and avoid chromosomal deletions. NAR Cancer. 2020;2:zcaa028.","journal-title":"NAR Cancer"},{"key":"8215_CR10","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s12276-021-00689-6","volume":"53","author":"HJ Kang","year":"2021","unstructured":"Kang HJ, Eom HJ, Kim H, Myung K, Kwon HM, Choi JH. Thrap3 promotes R-loop resolution via interaction with methylated DDX5. Exp Mol Med. 2021;53:1602\u201311.","journal-title":"Exp Mol Med"},{"key":"8215_CR11","doi-asserted-by":"publisher","first-page":"e202000762.","DOI":"10.26508\/lsa.202000762","volume":"3","author":"OD Villarreal","year":"2020","unstructured":"Villarreal OD, Mersaoui SY, Yu Z, Masson JY, Richard S. Genome-wide R-loop analysis defines unique roles for DDX5, XRN2, and PRMT5 in DNA\/RNA hybrid resolution. Life Sci Alliance. 2020;3:e202000762.","journal-title":"Life Sci Alliance"},{"key":"8215_CR12","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2020106018","volume":"40","author":"G Sessa","year":"2021","unstructured":"Sessa G, Gomez-Gonzalez B, Silva S, Perez-Calero C, Beaurepere R, Barroso S, et al. BRCA2 promotes DNA-RNA hybrid resolution by DDX5 helicase at DNA breaks to facilitate their repair. EMBO J. 2021;40:e106018.","journal-title":"EMBO J"},{"key":"8215_CR13","doi-asserted-by":"publisher","first-page":"E8392","DOI":"10.1073\/pnas.1711283114","volume":"114","author":"XA Su","year":"2017","unstructured":"Su XA, Freudenreich CH. Cytosine deamination and base excision repair cause R-loop-induced CAG repeat fragility and instability in Saccharomyces cerevisiae. Proc Natl Acad Sci USA. 2017;114:E8392\u2013E401.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8215_CR14","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1038\/s41588-023-01504-w","volume":"55","author":"JL McCann","year":"2023","unstructured":"McCann JL, Cristini A, Law EK, Lee SY, Tellier M, Carpenter MA, et al. APOBEC3B regulates R-loops and promotes transcription-associated mutagenesis in cancer. Nat Genet. 2023;55:1721\u201334.","journal-title":"Nat Genet"},{"key":"8215_CR15","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.molcel.2019.10.010","volume":"77","author":"DA Matos","year":"2020","unstructured":"Matos DA, Zhang JM, Ouyang J, Nguyen HD, Genois MM, Zou L. ATR protects the genome against R loops through a mus81-triggered feedback loop. Mol Cell. 2020;77:514\u201327.e4.","journal-title":"Mol Cell"},{"key":"8215_CR16","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.cell.2017.07.043","volume":"170","author":"S Hamperl","year":"2017","unstructured":"Hamperl S, Bocek MJ, Saldivar JC, Swigut T, Cimprich KA. Transcription-replication conflict orientation modulates r-loop levels and activates distinct dna damage responses. Cell. 2017;170:774\u201386.e19.","journal-title":"Cell"},{"key":"8215_CR17","doi-asserted-by":"publisher","first-page":"11668","DOI":"10.1093\/nar\/gkad839","volume":"51","author":"B Zhang","year":"2023","unstructured":"Zhang B, Li Y, Zhang J, Wang Y, Liang C, Lu T. et al. ADAR1 links R-loop homeostasis to ATR activation in replication stress response. Nucleic Acids Res. 2023;51:11668\u201387.","journal-title":"Nucleic Acids Res"},{"key":"8215_CR18","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1093\/nar\/gkq174","volume":"38","author":"EW Refsland","year":"2010","unstructured":"Refsland EW, Stenglein MD, Shindo K, Albin JS, Brown WL, Harris RS. Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction. Nucleic Acids Res. 2010;38:4274\u201384.","journal-title":"Nucleic Acids Res"},{"key":"8215_CR19","doi-asserted-by":"publisher","first-page":"2866","DOI":"10.1093\/bioinformatics\/btw230","volume":"32","author":"GY Di Veroli","year":"2016","unstructured":"Di Veroli GY, Fornari C, Wang D, Mollard S, Bramhall JL, Richards FM, et al. Combenefit: an interactive platform for the analysis and visualization of drug combinations. Bioinformatics. 2016;32:2866\u20138.","journal-title":"Bioinformatics"},{"key":"8215_CR20","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","volume":"70","author":"TC Chou","year":"2010","unstructured":"Chou TC. Drug combination studies and their synergy quantification using the Chou-Talalay method. Cancer Res. 2010;70:440\u20136.","journal-title":"Cancer Res"},{"key":"8215_CR21","doi-asserted-by":"crossref","unstructured":"Bartha A, Gyorffy B. TNMplot.com: a web tool for the comparison of gene expression in normal, tumor and metastatic tissues. Int J Mol Sci. 2021;22.","DOI":"10.3390\/ijms22052622"},{"key":"8215_CR22","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1158\/2159-8290.CD-13-0219","volume":"3","author":"MJ Ellis","year":"2013","unstructured":"Ellis MJ, Gillette M, Carr SA, Paulovich AG, Smith RD, Rodland KK, et al. Connecting genomic alterations to cancer biology with proteomics: the NCI clinical proteomic tumor analysis consortium. Cancer Discov. 2013;3:1108\u201312.","journal-title":"Cancer Discov"},{"key":"8215_CR23","doi-asserted-by":"crossref","unstructured":"Gyorffy B. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Br J Pharmacol. 2024;181:362\u201374.","DOI":"10.1111\/bph.16257"},{"key":"8215_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-021-04130-7","volume":"22","author":"HE Miller","year":"2021","unstructured":"Miller HE, Bishop AJR. Correlation analyzeR: functional predictions from gene co-expression correlations. BMC Bioinforma. 2021;22:206.","journal-title":"BMC Bioinforma"},{"key":"8215_CR25","doi-asserted-by":"publisher","first-page":"bbab260.","DOI":"10.1093\/bib\/bbab260","volume":"22","author":"D Maeser","year":"2021","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22:bbab260.","journal-title":"Brief Bioinform"},{"key":"8215_CR26","doi-asserted-by":"publisher","unstructured":"Ramirez P, Crouch RJ, Cheung VG, Grunseich C. R-Loop analysis by dot-blot. J Vis Exp. 2021. https:\/\/doi.org\/10.3791\/62069.","DOI":"10.3791\/62069"},{"key":"8215_CR27","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/febs.16202","volume":"289","author":"D Constantin","year":"2022","unstructured":"Constantin D, Dubuis G, Conde-Rubio MDC, Widmann C. APOBEC3C, a nucleolar protein induced by genotoxins, is excluded from DNA damage sites. FEBS J. 2022;289:808\u201331.","journal-title":"FEBS J"},{"key":"8215_CR28","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1158\/1541-7786.MCR-17-0019","volume":"15","author":"D Menendez","year":"2017","unstructured":"Menendez D, Nguyen TA, Snipe J, Resnick MA. The cytidine deaminase APOBEC3 family is subject to transcriptional regulation by p53. Mol Cancer Res. 2017;15:735\u201343.","journal-title":"Mol Cancer Res"},{"key":"8215_CR29","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.02200","volume":"3","author":"MA Allen","year":"2014","unstructured":"Allen MA, Andrysik Z, Dengler VL, Mellert HS, Guarnieri A, Freeman JA, et al. Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms. Elife. 2014;3:e02200.","journal-title":"Elife"},{"key":"8215_CR30","doi-asserted-by":"publisher","first-page":"7286","DOI":"10.1093\/nar\/gkt504","volume":"41","author":"D Menendez","year":"2013","unstructured":"Menendez D, Nguyen TA, Freudenberg JM, Mathew VJ, Anderson CW, Jothi R, et al. Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human cancer cells. Nucleic Acids Res. 2013;41:7286\u2013301.","journal-title":"Nucleic Acids Res"},{"key":"8215_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-018-0459-5","volume":"15","author":"BD Anderson","year":"2018","unstructured":"Anderson BD, Ikeda T, Moghadasi SA, Martin AS, Brown WL, Harris RS. Natural APOBEC3C variants can elicit differential HIV-1 restriction activity. Retrovirology. 2018;15:78.","journal-title":"Retrovirology"},{"key":"8215_CR32","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1158\/2159-8290.CD-20-0725","volume":"11","author":"S Venkatesan","year":"2021","unstructured":"Venkatesan S, Angelova M, Puttick C, Zhai H, Caswell DR, Lu WT, et al. Induction of APOBEC3 exacerbates DNA replication stress and chromosomal instability in early breast and lung cancer evolution. Cancer Discov. 2021;11:2456\u201373.","journal-title":"Cancer Discov"},{"key":"8215_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25904-w","volume":"12","author":"PA Konstantinopoulos","year":"2021","unstructured":"Konstantinopoulos PA, da Costa A, Gulhan D, Lee EK, Cheng SC, Hendrickson AEW, et al. A replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and atr inhibitor therapy in ovarian cancer. Nat Commun. 2021;12:5574.","journal-title":"Nat Commun"},{"key":"8215_CR34","doi-asserted-by":"publisher","first-page":"7655","DOI":"10.1093\/nar\/gkx345","volume":"45","author":"EK Schutsky","year":"2017","unstructured":"Schutsky EK, Nabel CS, Davis AKF, DeNizio JE, Kohli RM. APOBEC3A efficiently deaminates methylated, but not TET-oxidized, cytosine bases in DNA. Nucleic Acids Res. 2017;45:7655\u201365.","journal-title":"Nucleic Acids Res"},{"key":"8215_CR35","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1080\/15384101.2016.1152426","volume":"15","author":"AM Green","year":"2016","unstructured":"Green AM, Landry S, Budagyan K, Avgousti DC, Shalhout S, Bhagwat AS, et al. APOBEC3A damages the cellular genome during DNA replication. Cell Cycle. 2016;15:998\u20131008.","journal-title":"Cell Cycle"},{"key":"8215_CR36","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/embor.2011.46","volume":"12","author":"S Landry","year":"2011","unstructured":"Landry S, Narvaiza I, Linfesty DC, Weitzman MD. APOBEC3A can activate the DNA damage response and cause cell-cycle arrest. EMBO Rep. 2011;12:444\u201350.","journal-title":"EMBO Rep"},{"key":"8215_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40941-8","volume":"9","author":"M Niocel","year":"2019","unstructured":"Niocel M, Appourchaux R, Nguyen XN, Delpeuch M, Cimarelli A. The DNA damage induced by the Cytosine Deaminase APOBEC3A leads to the production of ROS. Sci Rep. 2019;9:4714.","journal-title":"Sci Rep"},{"key":"8215_CR38","doi-asserted-by":"publisher","first-page":"4567","DOI":"10.1158\/0008-5472.CAN-16-3389","volume":"77","author":"R Buisson","year":"2017","unstructured":"Buisson R, Lawrence MS, Benes CH, Zou L. APOBEC3A and APOBEC3B activities render cancer cells susceptible to ATR inhibition. Cancer Res. 2017;77:4567\u201378.","journal-title":"Cancer Res"},{"key":"8215_CR39","doi-asserted-by":"publisher","first-page":"4579","DOI":"10.1158\/0008-5472.CAN-16-3394","volume":"77","author":"AM Green","year":"2017","unstructured":"Green AM, Budagyan K, Hayer KE, Reed MA, Savani MR, Wertheim GB, et al. Cytosine deaminase APOBEC3A Sensitizes Leukemia cells to inhibition of the DNA replication checkpoint. Cancer Res. 2017;77:4579\u201388.","journal-title":"Cancer Res"},{"key":"8215_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-05867-0","volume":"14","author":"C Zong","year":"2023","unstructured":"Zong C, Zhang Z, Gao L, He J, Wang Y, Li Q, et al. APOBEC3B coordinates R-loop to promote replication stress and sensitize cancer cells to ATR\/Chk1 inhibitors. Cell Death Dis. 2023;14:348.","journal-title":"Cell Death Dis"},{"key":"8215_CR41","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1093\/nar\/gkt898","volume":"42","author":"AV Horn","year":"2014","unstructured":"Horn AV, Klawitter S, Held U, Berger A, Vasudevan AA, Bock A, et al. Human LINE-1 restriction by APOBEC3C is deaminase independent and mediated by an ORF1p interaction that affects LINE reverse transcriptase activity. Nucleic Acids Res. 2014;42:396\u2013416.","journal-title":"Nucleic Acids Res"},{"key":"8215_CR42","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1080\/1120009X.2022.2082350","volume":"35","author":"S Pan","year":"2023","unstructured":"Pan S, Li R, Tao L. Correlation of gemcitabine sensitization by Chk1 inhibition with p53 status. J Chemother. 2023;35:270\u20134.","journal-title":"J Chemother"},{"key":"8215_CR43","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1158\/0008-5472.CAN-14-3347","volume":"75","author":"SB Koh","year":"2015","unstructured":"Koh SB, Courtin A, Boyce RJ, Boyle RG, Richards FM, Jodrell DI. CHK1 inhibition synergizes with gemcitabine initially by destabilizing the DNA replication apparatus. Cancer Res. 2015;75:3583\u201395.","journal-title":"Cancer Res"},{"key":"8215_CR44","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrc3352","volume":"12","author":"JV Forment","year":"2012","unstructured":"Forment JV, Kaidi A, Jackson SP. Chromothripsis and cancer: causes and consequences of chromosome shattering. Nat Rev Cancer. 2012;12:663\u201370.","journal-title":"Nat Rev Cancer"},{"key":"8215_CR45","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/nature10802","volume":"482","author":"K Crasta","year":"2012","unstructured":"Crasta K, Ganem NJ, Dagher R, Lantermann AB, Ivanova EV, Pan Y, et al. DNA breaks and chromosome pulverization from errors in mitosis. Nature. 2012;482:53\u20138.","journal-title":"Nature"},{"key":"8215_CR46","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1101\/gr.237362.118","volume":"28","author":"IX Wang","year":"2018","unstructured":"Wang IX, Grunseich C, Fox J, Burdick J, Zhu Z, Ravazian N, et al. Human proteins that interact with RNA\/DNA hybrids. Genome Res. 2018;28:1405\u201314.","journal-title":"Genome Res"},{"key":"8215_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcpro.2024.100755","volume":"23","author":"GM Jang","year":"2024","unstructured":"Jang GM, Annan Sudarsan AK, Shayeganmehr A, Prando Munhoz E, Lao R, Gaba A, et al. Protein interaction map of APOBEC3 enzyme family reveals deamination-independent role in cellular function. Mol Cell Proteom. 2024;23:100755.","journal-title":"Mol Cell Proteom"},{"key":"8215_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27530-y","volume":"12","author":"T Mosler","year":"2021","unstructured":"Mosler T, Conte F, Longo GMC, Mikicic I, Kreim N, Mockel MM, et al. R-loop proximity proteomics identifies a role of DDX41 in transcription-associated genomic instability. Nat Commun. 2021;12:7314.","journal-title":"Nat Commun"},{"key":"8215_CR49","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1158\/2767-9764.CRC-24-0442","volume":"5","author":"NMG Garcia","year":"2025","unstructured":"Garcia NMG, Becerra JN, Srinivasan S, McKinney BJ, DiMarco AV, Wu F, et al. APOBEC3 activity promotes the survival and evolution of drug-tolerant persister cells during EGFR inhibitor resistance in lung cancer. Cancer Res Commun. 2025;5:825\u201340.","journal-title":"Cancer Res Commun"},{"key":"8215_CR50","unstructured":"Anderson BD, Harris RS. APOBEC3 transcriptional regulation and HIV-1 restriction in T lymphocytes. University of Minnesota, USA; 2017."},{"key":"8215_CR51","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/bs.mcb.2022.10.008","volume":"182","author":"A Dananberg","year":"2024","unstructured":"Dananberg A, Maciejowski J. Monitoring APOBEC3A protein levels in human cancer cells. Methods Cell Biol. 2024;182:313\u201327.","journal-title":"Methods Cell Biol"},{"key":"8215_CR52","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1016\/j.molcel.2022.05.004","volume":"82","author":"S Saxena","year":"2022","unstructured":"Saxena S, Zou L. Hallmarks of DNA replication stress. Mol Cell. 2022;82:2298\u2013314.","journal-title":"Mol Cell"},{"key":"8215_CR53","doi-asserted-by":"crossref","unstructured":"Pereira S, Fernandes PA, Ramos MJ. Mechanism for ribonucleotide reductase inactivation by the anticancer drug gemcitabine. J Comput Chem. 2004;25:1286\u201394.","DOI":"10.1002\/jcc.20054"},{"key":"8215_CR54","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/nrd4553","volume":"14","author":"M Dobbelstein","year":"2015","unstructured":"Dobbelstein M, Sorensen CS. Exploiting replicative stress to treat cancer. Nat Rev Drug Discov. 2015;14:405\u201323.","journal-title":"Nat Rev Drug Discov"},{"key":"8215_CR55","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1101\/gr.197046.115","volume":"26","author":"VB Seplyarskiy","year":"2016","unstructured":"Seplyarskiy VB, Soldatov RA, Popadin KY, Antonarakis SE, Bazykin GA, Nikolaev SI. APOBEC-induced mutations in human cancers are strongly enriched on the lagging DNA strand during replication. Genome Res. 2016;26:174\u201382.","journal-title":"Genome Res"},{"key":"8215_CR56","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/bjc.2017.133","volume":"117","author":"J Nikkila","year":"2017","unstructured":"Nikkila J, Kumar R, Campbell J, Brandsma I, Pemberton HN, Wallberg F, et al. Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells. Br J Cancer. 2017;117:113\u201323.","journal-title":"Br J Cancer"},{"key":"8215_CR57","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13045-023-01425-5","volume":"16","author":"K Butler","year":"2023","unstructured":"Butler K, Banday AR. APOBEC3-mediated mutagenesis in cancer: causes, clinical significance and therapeutic potential. J Hematol Oncol. 2023;16:31.","journal-title":"J Hematol Oncol"},{"key":"8215_CR58","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1074\/jbc.RA118.005231","volume":"294","author":"NJH Warren","year":"2019","unstructured":"Warren NJH, Eastman A. Inhibition of checkpoint kinase 1 following gemcitabine-mediated S phase arrest results in CDC7- and CDK2-dependent replication catastrophe. J Biol Chem. 2019;294:1763\u201378.","journal-title":"J Biol Chem"},{"key":"8215_CR59","doi-asserted-by":"publisher","first-page":"201932","DOI":"10.1098\/rsos.201932","volume":"8","author":"C Mocanu","year":"2021","unstructured":"Mocanu C, Chan KL. Mind the replication gap. R Soc Open Sci. 2021;8:201932.","journal-title":"R Soc Open Sci"},{"key":"8215_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2727-2","volume":"11","author":"J Choo","year":"2020","unstructured":"Choo J, Schlosser D, Manzini V, Magerhans A, Dobbelstein M. The integrated stress response induces R-loops and hinders replication fork progression. Cell Death Dis. 2020;11:538.","journal-title":"Cell Death Dis"},{"key":"8215_CR61","doi-asserted-by":"publisher","first-page":"16090","DOI":"10.1073\/pnas.1005031107","volume":"107","author":"E Petermann","year":"2010","unstructured":"Petermann E, Woodcock M, Helleday T. Chk1 promotes replication fork progression by controlling replication initiation. Proc Natl Acad Sci USA. 2010;107:16090\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8215_CR62","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.gde.2021.07.003","volume":"71","author":"A Simoneau","year":"2021","unstructured":"Simoneau A, Zou L. An extending ATR-CHK1 circuitry: the replication stress response and beyond. Curr Opin Genet Dev. 2021;71:92\u20138.","journal-title":"Curr Opin Genet Dev"},{"key":"8215_CR63","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41594-018-0171-0","volume":"26","author":"YH Chen","year":"2019","unstructured":"Chen YH, Keegan S, Kahli M, Tonzi P, Fenyo D, Huang TT, et al. Transcription shapes DNA replication initiation and termination in human cells. Nat Struct Mol Biol. 2019;26:67\u201377.","journal-title":"Nat Struct Mol Biol"},{"key":"8215_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.110176","volume":"37","author":"B Martinez-Pastor","year":"2021","unstructured":"Martinez-Pastor B, Silveira GG, Clarke TL, Chung D, Gu Y, Cosentino C, et al. Assessing kinetics and recruitment of DNA repair factors using high content screens. Cell Rep. 2021;37:110176.","journal-title":"Cell Rep"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08215-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08215-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08215-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:03:07Z","timestamp":1767801787000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08215-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8215"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08215-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"9 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}